SCINAI IMMUNOTHERAPEUTICS LTD. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
SCINAI IMMUNOTHERAPEUTICS LTD. (SCNI) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $952.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2026-04-01.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-04-01
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|
| 2024-12-31 | $952.00K 20-F · filed 2026-04-01 |
| 2023-12-31 | $252.00K 20-F · filed 2024-05-15 |
| 2022-12-31 | $355.00K 20-F · filed 2024-05-15 |
| 2021-12-31 | $97.00K 20-F · filed 2024-05-15 |